12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AMR102: Clinical trial ongoing

Amarin completed dosing in an open-label, U.S. clinical trial evaluating multiple doses of AMR102 in 48 healthy volunteers. Amarin's Vascepa is approved in the...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >